IUD
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
2 programsInstructions for IUD Self-Removal Provided to ParticipantN/A1 trial
Menstrual disc with EMLA creamN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
AspivixCarevix
Oregon TherapeuticsMenstrual disc with EMLA cream
Oregon TherapeuticsInstructions for IUD Self-Removal Provided to Participant
Clinical Trials (3)
Total enrollment: 154 patients across 3 trials
Assessing Pain and Effectiveness of Carevix Device for IUD Insertions
Start: Feb 2026Est. completion: Feb 2027100 patients
N/ANot Yet Recruiting
Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
Start: Aug 2025Est. completion: Apr 202624 patients
N/ARecruiting
IUD Self-Removal Study
Start: Jun 2022Est. completion: Oct 202530 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 154 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.